Global Analytical Microbiology Expert
Sanofi Pasteur
Thierry Bonnevay has more than 25 years of experience in the field of microbiological quality control, acquired
within the Sanofi Vaccine and has held various positions in this field both in industrial affairs and in R&D. He is a member of the European Pharmacopoeia Expert Group EDQM within Group 1 Microbiology (since 2016), the
Bacterial Endotoxins Working Group (WP BET) since 2017 and the Mycoplasma Working Group (WP MYC) since 2018. Finally, he is part of the board of the French association A3P since 2017.
R&D Senior Manager
bioMérieux
Laurent Leblanc is R&D Sr. Manager for bioMérieux’ Pharma Quality Control business. He holds a master’s degree in biotechnology from the University of Limoges, France. For the last 20 years, he worked in several biotechnology companies and before joining bioMérieux in 2008 worked in microbiological quality control in the pharmaceutical industry. He is now involved in designing and bringing to the market the new innovative and efficient solutions
dedicated to the pharmaceutical and cosmetic industries.
The Environmental Monitoring program is an important quality control for the pharmaceutical manufacturing operations. The most common usage is doing sequential incubation time and temperature to maximize the range of recovery of the flora. The current practice is to start with the lower temperature (22,5°) to enhance the growth of environmental strains such as molds and to switch to the higher temperature (32,5°C) to recover human skin microorganisms.
The rest of longer description is here.